\ February 17, 2016 /
A cancer therapy involving a patient's own immune cells is showing extraordinary results in leukemia patients, researchers say.
In the latest study, U.S. researchers used genetically modified T-cells in 35 terminally ill patients with leukemia, and 94 percent went into remission.
"A type of blood cell in the body called a T-cell was reengineered and tricked into fighting the cancer," Perlmutter Cancer Center's Dr. Michael Grossbard, a specialist in leukemia, lymphoma and oncology, told CBS News.
Visit: http://www.cbsnews.com/news/cancer-t-cell-treatment-extraordinary-results-in-study/?google_editors_picks=true to read the full article and watch the video.